# Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

> **NCT01925170** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 1638 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Molecular Breast Imaging
- **DEVICE:** Conventional Mammography
- **DRUG:** Technetium (99mTc) sestamibi

## Key facts

- **NCT ID:** NCT01925170
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 1638 (ACTUAL)
- **Last updated:** 2014-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925170, "Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01925170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*